Premium
Feasibility, acceptability, and preliminary efficacy of a technology‐assisted psychosocial intervention for racially diverse men with advanced prostate cancer
Author(s) -
Yanez Betina,
McGinty Heather L.,
Mohr David C.,
Begale Mark J.,
Dahn Jason R.,
Flury Sarah C.,
Perry Kent T.,
Penedo Frank J.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29658
Subject(s) - medicine , psychosocial , psychological intervention , quality of life (healthcare) , attendance , randomized controlled trial , distress , physical therapy , prostate cancer , stress management , cancer , clinical psychology , psychiatry , nursing , economics , economic growth
BACKGROUND The utility of psychosocial interventions in reducing symptom burden and improving health‐related quality of life (HRQOL) for men with localized prostate cancer has been demonstrated. However, studies have yet to demonstrate the efficacy of interventions in advanced prostate cancer (APC). This study examined the feasibility, acceptability, and preliminary efficacy of a technology‐assisted, 10‐week, group‐based psychosocial intervention for diverse men with APC. METHODS The participants were 74 men (mean age, 68.84 years; non‐Hispanic white, 57%; black, 40.5%) who were randomized to a cognitive‐behavioral stress management (CBSM) treatment or health promotion (HP) attention‐control condition. The participants were assessed at the baseline, weekly throughout the 10‐week program, and 6 months after the baseline. Outcomes were assessed with the Patient‐Reported Outcomes Measurement Information System along with established measures of HRQOL, CBSM intervention targets (eg, relaxation skills), and patient‐reported acceptability. RESULTS Feasibility was demonstrated through good retention rates (>85%) and acceptable average attendance rates (>70%), and acceptability was demonstrated through very favorable weekly session evaluations (mean score, 4/5) and exit surveys (mean score, 3.6/4). Men randomized to the CBSM condition reported significant reductions ( P < .05) in depressive symptoms and improvements in relaxation self‐efficacy ( P < .05) at the 6‐month follow‐up. CBSM participants reported trends for improvement in distress and functional well‐being ( P < .08) in comparison with those in the HP condition. Effect sizes ranged from medium (0.54) to large (1.87) and, in some instances, were clinically meaningful. CONCLUSIONS Technology‐based CBSM interventions among diverse men with APC may be feasible, acceptable, and efficacious. Cancer 2015;121:4407–15 . © 2015 American Cancer Society .